Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Coronavirus Update: R&D Starts, Product Delays, Continuing Collaboration

Mar 30 2020

• By Pink Sheet Team

The world health organization WHO declares an international emergency in connection with the outbreak of new pneumonia in China caused by the coronavirus 2019-nCoV virus — The coronavirus is continuing its spread • Source: Shutterstock

Related Content

EU Hat Trick For Bluebird’s Beta-Thalassemia Gene Therapy

Mar 29 2019

Keeping Track: US FDA Okays BMS’ Zeposia In MS, Nixes Lilly/BI’s Empagliflozin For Type 1 Diabetes

Mar 29 2020

Related Companies

Boehringer Ingelheim GmbH

bioMerieux SA

Eisai Co., Ltd.

Eli Lilly and Company

Gilead Sciences, Inc.

GSK plc

Johnson & Johnson

Merck & Co., Inc.

Merck KGaA

Novartis AG

Pfizer Inc.

Sanofi

Bristol Myers Squibb Company

AbbVie Inc.

Viatris Inc.

Intercept Pharmaceuticals, Inc.

Genetix Biotherapeutics

Healios K.K.

Athersys, Inc.

Celltrion, Inc.

Vir Biotechnology, Inc.

WuXi AppTec

Biogen, Inc.

Golden Meditech Holdings Limited

Regeneron Pharmaceuticals, Inc.

Moderna, Inc.

Additional Topics

International Coronavirus COVID-19 Drug Review Regulation BioPharmaceutical

More from Product Reviews

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window